Skip to main content

Imaging studies of patients with malignant fibrous histiocytoma using C-11-alpha-aminoisobutyric acid (AIB).

Publication ,  Journal Article
Schmall, B; Conti, PS; Bigler, RE; Zanzonico, PB; Reiman, RE; Benua, RS; Yeh, SD; Dahl, JR; Lee, R; Laughlin, JS
Published in: Clin Nucl Med
January 1987

Alpha-aminoisobutyric acid (AIB), a synthetic, nonmetabolized amino acid which is rapidly transported into viable cells by the A-type or alanine-preferring amino acid transport system, has been labeled with the short-lived, positron-emitting radionuclide carbon-11. Carbon-11 labeled AIB is currently being evaluated as a tumor imaging agent for in vivo amino acid transport studies in patients with cancer. In this study, C-11 AIB was used to image two patients with malignant fibrous histiocytoma (MFH), a pleomorphic sarcoma. Following intravenous administration of C-11 AIB, tumors in the distal femur of one patient and in the anterior chest wall of another patient were well visualized using high energy gamma scintigraphy. Since therapy may alter the accumulation of amino acids in tumor tissue, studies using C-11 AIB in patients with MFH before and after chemotherapy are in progress.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Clin Nucl Med

DOI

ISSN

0363-9762

Publication Date

January 1987

Volume

12

Issue

1

Start / End Page

22 / 26

Location

United States

Related Subject Headings

  • Thoracic Neoplasms
  • Technetium Tc 99m Medronate
  • Radionuclide Imaging
  • Nuclear Medicine & Medical Imaging
  • Middle Aged
  • Male
  • Humans
  • Histiocytoma, Benign Fibrous
  • Gallium Radioisotopes
  • Femoral Neoplasms
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Schmall, B., Conti, P. S., Bigler, R. E., Zanzonico, P. B., Reiman, R. E., Benua, R. S., … Laughlin, J. S. (1987). Imaging studies of patients with malignant fibrous histiocytoma using C-11-alpha-aminoisobutyric acid (AIB). Clin Nucl Med, 12(1), 22–26. https://doi.org/10.1097/00003072-198701000-00005
Schmall, B., P. S. Conti, R. E. Bigler, P. B. Zanzonico, R. E. Reiman, R. S. Benua, S. D. Yeh, J. R. Dahl, R. Lee, and J. S. Laughlin. “Imaging studies of patients with malignant fibrous histiocytoma using C-11-alpha-aminoisobutyric acid (AIB).Clin Nucl Med 12, no. 1 (January 1987): 22–26. https://doi.org/10.1097/00003072-198701000-00005.
Schmall B, Conti PS, Bigler RE, Zanzonico PB, Reiman RE, Benua RS, et al. Imaging studies of patients with malignant fibrous histiocytoma using C-11-alpha-aminoisobutyric acid (AIB). Clin Nucl Med. 1987 Jan;12(1):22–6.
Schmall, B., et al. “Imaging studies of patients with malignant fibrous histiocytoma using C-11-alpha-aminoisobutyric acid (AIB).Clin Nucl Med, vol. 12, no. 1, Jan. 1987, pp. 22–26. Pubmed, doi:10.1097/00003072-198701000-00005.
Schmall B, Conti PS, Bigler RE, Zanzonico PB, Reiman RE, Benua RS, Yeh SD, Dahl JR, Lee R, Laughlin JS. Imaging studies of patients with malignant fibrous histiocytoma using C-11-alpha-aminoisobutyric acid (AIB). Clin Nucl Med. 1987 Jan;12(1):22–26.

Published In

Clin Nucl Med

DOI

ISSN

0363-9762

Publication Date

January 1987

Volume

12

Issue

1

Start / End Page

22 / 26

Location

United States

Related Subject Headings

  • Thoracic Neoplasms
  • Technetium Tc 99m Medronate
  • Radionuclide Imaging
  • Nuclear Medicine & Medical Imaging
  • Middle Aged
  • Male
  • Humans
  • Histiocytoma, Benign Fibrous
  • Gallium Radioisotopes
  • Femoral Neoplasms